Cathy Bull

654 total citations
15 papers, 363 citations indexed

About

Cathy Bull is a scholar working on Molecular Biology, Epidemiology and Organic Chemistry. According to data from OpenAlex, Cathy Bull has authored 15 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Epidemiology and 2 papers in Organic Chemistry. Recurrent topics in Cathy Bull's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Herpesvirus Infections and Treatments (3 papers) and Advanced Breast Cancer Therapies (2 papers). Cathy Bull is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Herpesvirus Infections and Treatments (3 papers) and Advanced Breast Cancer Therapies (2 papers). Cathy Bull collaborates with scholars based in United States, Germany and Australia. Cathy Bull's co-authors include Claudia Schneider, Dean Wilkie, Christoph A. Schatz, Scott M. Wilhelm, Ningshu Liu, Andrea Haegebarth, William J. Scott, Martin Hentemann, Bruce R. Rowley and Dominik Mumberg and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Cathy Bull

14 papers receiving 353 citations

Peers

Countries citing papers authored by Cathy Bull

Since Specialization

Citations

This map shows the geographic impact of Cathy Bull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Bull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Bull more than expected).

Fields of papers citing papers by Cathy Bull

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy Bull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Bull. The network helps show where Cathy Bull may publish in the future.

Co-authorship network of co-authors of Cathy Bull

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy Bull. A scholar is included among the top collaborators of Cathy Bull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy Bull. Cathy Bull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Emergency department presentations for deliberate self-harm and suicidal ideation in 25–39 year olds following agency-notified child maltreatment: results from the Childhood Adversity and Lifetime Morbidity (CALM) study 2024 ·Epidemiology and Psychiatric Sciences ·Steve Kisely, Cathy Bull, Mike Trott, Urška Arnautovska, Dan Siskind, Nicola Warren, Jake M. Najman	1
2	Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor 2016 ·Journal of Medicinal Chemistry ·Jean‐Marc Lapierre, Sudharshan Eathiraj, (unknown), Yanbin Liu, Cathy Bull, Susan Cornell-Kennon, Shin Iimura, (unknown), Darin Kizer, Steffi Koerner, Sapna Makhija, Akihisa Matsuda, Magdi Moussa, Nivedita Namdev, Ronald E. Savage, (unknown), Erika Volckova, Neil Westlund, Hui Wu, Brian Schwartz	87
3	BAY 80-6946 Is a Highly Selective Intravenous PI3K Inhibitor with Potent p110α and p110δ Activities in Tumor Cell Lines and Xenograft Models 2013 ·Molecular Cancer Therapeutics ·Ningshu Liu, Bruce R. Rowley, Cathy Bull, Claudia Schneider, Andrea Haegebarth, Christoph A. Schatz, (unknown), Dean Wilkie, Martin Hentemann, Scott M. Wilhelm, William J. Scott, Dominik Mumberg, Karl Ziegelbauer	206
4	Abstract A278: ARQ 087, a multi-tyrosine kinase inhibitor with potent in vitro and in vivo activity in FGFR2 driven models. 2013 ·Molecular Cancer Therapeutics ·Daniel T. Dransfield, Jennifer Lee, Carol Waghorne, Cathy Bull, Ronald E. Savage, Xiaolan Zhao, (unknown), Edward Chang, (unknown), Sudharshan Eathiraj, Susan Cornell-Kennon, Xiubin Gu, Syed Muhammad Adnan Ali, Chang-Rung Chen	4
5	Abstract A230: Discovery and characterization of ARQ 092, an ATP-independent, potent and selective inhibitor of AKT kinases. 2011 ·Molecular Cancer Therapeutics ·Thomas Chan, Jean‐Marc Lapierre, Mark A. Ashwell, Dennis S. France, Chang-Rung Chen, Susan Cornell-Kennon, Cathy Bull, (unknown), Rocio Palma, Yanbin Liu, Sapna Makhija, Carol Waghorne, (unknown), Kôsaku Fujiwara	3
6	Abstract 3571: Exploratory biomarker discovery for clinical development of ARQ 087, a potent pan-FGFR kinase inhibitor 2011 ·Cancer Research ·Yi Yu, Xiubin Gu, (unknown), Xiaolan Zhao, Edward Chang, (unknown), (unknown), Laura A. Cousens, Cathy Bull, Yunxia Wang, (unknown), Carol Waghorne, Chang-Rung Chen, Dennis S. France, Edwin Clark, Thomas Chan	1
7	Abstract 4476: BAY 80-6946, a highly selective and potent pan class I PI3K inhibitor induces tumor apoptosis in vitro and tumor regression in vivo in a sub-set of tumor models 2010 ·Cancer Research ·Ningshu Liu, Bruce R. Rowley, Claudia Schneider, Cathy Bull, (unknown), Martin Hentemann, William K. Scott, Dominik Mumberg, Karl Ziegelbauer	2
8	Abstract 2517: Pharmacodynamic biomarkers for ARQ 736, a small molecule BRAF inhibitor 2010 ·Cancer Research ·(unknown), Xiaolan Zhao, Xiubin Gu, Edward Chang, Laura A. Cousens, (unknown), (unknown), Yanbin Liu, Cathy Bull, Carol Waghorne, Thomas Chan	5
9	Abstract 4478: BAY 80-6946, a highly potent and efficacious class I PI3K inhibitor, induces complete tumor regression or tumor stasis in rat xenograft tumor models with PIK3CA mutant or PTEN deletion 2010 ·Cancer Research ·Ningshu Liu, Andrea Haegebarth, Cathy Bull, Christoph A. Schatz, Stefan Wiehr, Peter Hauff, Bernd J. Pichler, Dominik Mumberg, Susan Jenkins, Thomas Schwarz, Karl Ziegelbauer	2
10	Abstract 4501: Development and biological annotation of a novel RAF inhibitor amenable for clinical evaluation against BRAF (V600E)-harboring human tumors 2010 ·Cancer Research ·Chang-Rung Chen, Jean‐Marc Lapierre, (unknown), Yanbin Liu, Nivedita Namdev, (unknown), (unknown), Cathy Bull, Thomas Chan, Mark A. Ashwell, Dennis S. France	0
11	Gender and developmental patterns of affect, belief, and behavior in simulated injury events 1997 ·Journal of Applied Developmental Psychology ·Lizette Peterson, (unknown), (unknown), Cathy Bull	35
12	Identification of functional domains in murine granulocyte-macrophage colony-stimulating factor using monoclonal antibodies to synthetic peptides 1993 ·The Journal of Immunology ·Robert S. Greenfield, Gary R. Braslawsky, Kathleen F. Kadow, George L. Spitalny, Dana F. Chace, Cathy Bull, Isia Bursuker	6
13	Recurrent Genital Infection in the Guinea Pig: Differences between Herpes Simplex Types 1 and 2 1992 ·Intervirology ·Marie L. Landry, David Myerson, Cathy Bull	8
14	Herpes Simplex Types 1 and 2: Latency in the Genital Tract of Guinea Pigs 1992 ·Intervirology ·Marie L. Landry, Cathy Bull	1
15	Antiviral Activity of 5-Iodo-2’-Deoxyuridine and Related Drugs in Human Keratinocytes Infected in vitro with Herpes simplex Virus Type 1 1991 ·Skin Pharmacology and Physiology ·Haim Reuveni, Cathy Bull, Marie L. Landry, Leonard M. Milstone, Pauline M. Schwartz	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact